Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Erlotinib Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,005Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Accord healthcare

    02 3Alembic Pharmaceuticals Limited

    03 6Apotex Inc

    04 3Astellas Pharma

    05 3Aurobindo Pharma Limited

    06 2Chartwell Pharmaceuticals llc

    07 3Cipla

    08 3Cipla Medpro South Africa

    09 3Eurolab

    10 3F. Hoffmann-La Roche

    11 2Fujian South Pharmaceutical

    12 5Hetero Drugs

    13 3MSN Laboratories

    14 3Natco Pharma

    15 3Natco Pharma (Canada) Inc

    16 2Nishchay Pharmaceuticals Pvt. Ltd.

    17 1Pharmascience Inc.

    18 3Rising Pharmaceuticals Inc

    19 3Sandoz B2B

    20 3Shilpa Medicare

    21 6Sun Pharmaceutical Industries Limited

    22 3Tarbis Farma Sl

    23 12Teva Pharmaceutical Industries

    24 3Tillomed Laboratories Ltd

    25 3Zydus Pharmaceuticals

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Apotex Inc

    Canada
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Apotex Inc

    Canada
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Apotex Inc

    Canada
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208396

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Astellas Pharma

    Japan
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Astellas Pharma

    Japan
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Astellas Pharma

    Japan
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Astellas Pharma

    Japan
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : TARCEVA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Packaging :

    Approval Date : 2004-11-18

    Application Number : 21743

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Chartwell Pharmaceuticals llc

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Chartwell Pharmaceuticals llc

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2024-09-13

    Application Number : 203843

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Chartwell Pharmaceuticals llc

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Chartwell Pharmaceuticals llc

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2024-09-13

    Application Number : 203843

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Hetero Drugs

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Hetero Drugs

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Hetero Drugs

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Hetero Drugs

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2024-05-24

    Application Number : 209267

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Natco Pharma

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    Natco Pharma

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Natco Pharma

    India
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Natco Pharma

    India
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2019-11-05

    Application Number : 208488

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Rising Pharmaceuticals Inc

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Rising Pharmaceuticals Inc

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Rising Pharmaceuticals Inc

    U.S.A
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Rising Pharmaceuticals Inc

    U.S.A
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2014-06-11

    Application Number : 91002

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Teva Pharmaceutical Industries

    Israel
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 25MG BASE

    Packaging :

    Approval Date : 2020-11-09

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Teva Pharmaceutical Industries

    Israel
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 100MG BASE

    Packaging :

    Approval Date : 2015-08-28

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Teva Pharmaceutical Industries

    Israel
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Teva Pharmaceutical Industries

    Israel
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    ERLOTINIB HYDROCHLORIDE

    Brand Name : ERLOTINIB HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 150MG BASE

    Packaging :

    Approval Date : 2015-08-28

    Application Number : 91059

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF